食管癌穿孔后治疗的研究进展

Research progress on treatment of esophageal perforation in esophageal carcinoma

食管癌是中国常见的肿瘤之一,穿孔是食管癌常见的并发症。目前对于食管癌穿孔的治疗,不管是中国还是国际上缺乏统一的专家共识。本文应用PubMed、中国知网、万方数据库等检索平台系统,检索1996-2017年12月相关文献,筛选出27篇相关文献,并通过27篇文献对食管癌穿孔的发生机制、临床特点进行分析。可手术患者可延长生存,但同时围手术期并发症风险提高,而营养支持下同步放化疗也可明显延长生存。

Esophageal cancer is one of the common tumors in China. Esophageal perforation is a common complication of esophageal carcinoma. Currently, there is no consensus on the treatment of esophageal perforation of esophageal carcinoma at home and abroad. Twenty-seven articles were selected from PubMed, CNKI and Wanfang database between 1997 to December 2017. The mechanism of esophageal perforation and clinical characteristics in these 27 articles were analyzed. Surgery can improve the survival rate, but the risk of perioperative complications may be increased. Concurrent chemoradiotherapy with nutritional support can significantly improve the survival rate.